Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee-Reference-Cited by-同舟云学术

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Published:2016-11 Issue:11 Volume:22 Page:1915-1925
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Palmer Jeanne,McCune Jeannine S.^ORCID,Perales Miguel-Angel,Marks David,Bubalo Joseph,Mohty Mohamad,Wingard John R.,Paci Angelo,Hassan Moustapha,Bredeson Christopher,Pidala Joseph,Shah Nina,Shaughnessy Paul,Majhail Navneet,Schriber Jeff,Savani Bipin N.,Carpenter Paul A.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference116 articles.

1. Treatment of polycythemia vera with busulfan (myleran);Louis;JAMA,1958

2. Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. “Leukemia and Hematosarcoma” Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.);Br J Cancer,1981

3. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia;Shvidel;Leukemia,2007

4. Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia;Santos;J Natl Cancer Inst,1974

5. Effect of busulfan on antibody production and skin allograft survival in the rat;Santos;J Natl Cancer Inst,1974

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

2. Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation;PLOS ONE;2023-10-26

3. Busulfan and subsequent malignancy: An evidence‐based risk assessment;Pediatric Blood & Cancer;2023-10-19

4. The presence of busulfan metabolites and pharmacometabolomics in plasma drawn immediately before allograft infusion in hematopoietic cell transplant recipients;Clinical and Translational Science;2023-10-10

5. Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration–Time Curve: Based on Peak and Trough Concentrations in Saliva;The Journal of Clinical Pharmacology;2023-09-29